Congresso Brasileiro de Transplantes (ABTO) 2021
Estudo de fase 2 para avaliar a eficácia e a segurança do pegcetacoplan no tratamento de participantes com recidiva pós-transplante de C3G ou IC-MPGN
Landing
Back to Conference Resources
The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.